Vivek Ramaswamy to launch run for Ohio governor next week [USA TODAY]
Roivant Sciences Ltd. (ROIV)
Company Research
Source: USA TODAY
Last week, Ramaswamy, 39, of Upper Arlington, set up a campaign committee to replace Gov. Mike DeWine, who cannot run for reelection due to term limits. Stay informed: Sign up for The Scoop, our weekly Ohio politics newsletter Ramaswamy's official launch will be next Monday at CTL Aerospace, Inc. followed by a stop at Axium Packaging in New Albany outside of Columbus, the Associated Press first reported . The following day, Ramaswamy will hold kick-off events in Toledo and Strongsville. The Republican primary to replace DeWine has already shifted multiple times even though the election is more than a year away. Former Lt. Gov. Jon Husted took a U.S. Senate appointment to replace Vice President JD Vance rather than run for governor. Ramaswamy has swept up multiple endorsements from senators and statewide elected officials even before his official launch. Ramaswamy will face Ohio Attorney General Dave Yost in the Republican primary. Lt. Gov. Jim Tressel, a prominent former Ohio
Show less
Read more
Impact Snapshot
Event Time:
ROIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ROIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ROIV alerts
High impacting Roivant Sciences Ltd. news events
Weekly update
A roundup of the hottest topics
ROIV
News
- Immunovant (IMVT) Is Up 14.0% After Roivant-Backed $550 Million Equity Raise For IMVT-1402 - Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
- Roivant Sciences (NASDAQ:ROIV) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $24.00 to $33.00. They now have a "buy" rating on the stock.MarketBeat
- Roivant Sciences (NASDAQ:ROIV) had its "outperform" rating reaffirmed by analysts at Leerink Partners.MarketBeat
- Roivant Sciences (NASDAQ:ROIV) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor DayGlobeNewswire
ROIV
Earnings
- 11/10/25 - Beat
ROIV
Sec Filings
- 12/17/25 - Form 4
- 12/17/25 - Form 144
- 12/15/25 - Form 4
- ROIV's page on the SEC website